HomeLBLTF • OTCMKTS
add
Lattice Biologics Ord Shs
Market news
Financials
Income Statement
Revenue
Net income
(USD) | 2020info | Y/Y change |
---|---|---|
Revenue | 2.46M | 12.60% |
Operating expense | 1.52M | -4.17% |
Net income | -1.48M | -46.52% |
Net profit margin | -60.16 | -30.13% |
Earnings per share | — | — |
EBITDA | -60.25K | 84.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | 2020info | Y/Y change |
---|---|---|
Cash and short-term investments | 57.22K | 265.18% |
Total assets | 3.02M | 32.68% |
Total liabilities | 9.42M | 9.69% |
Total equity | -6.40M | — |
Shares outstanding | 128.22M | — |
Price to book | -0.00 | — |
Return on assets | -7.93% | — |
Return on capital | 5.64% | — |
Cash Flow
Net change in cash
(USD) | 2020info | Y/Y change |
---|---|---|
Net income | -1.48M | -46.52% |
Cash from operations | 536.15K | 231.72% |
Cash from investing | -592.08K | -1,039.33% |
Cash from financing | 97.48K | 197.05% |
Net change in cash | 41.55K | 350.61% |
Free cash flow | -1.07M | -609.02% |
About
Founded
1989
Headquarters
Website